Manufacture

As world leaders commit to an ambitious reduction in AMR-related deaths, we ask is five years enough time to achieve it?

How CRISPR can change the way we design and produce antibodies.

Developing science is good; developing successful commercialization strategies is great.

Cell therapy has come a long way since the 1930s. Next, we need to find a way to bring the costs down by using allogeneic approaches.

A new drug delivery technique could eliminate needles from the vaccination process, as well as help the world prepare for the next pandemic.

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

The WHO called for an effective maternal GBS vaccine that could protect infants through transplacental transfer of maternal antibodies.

Jason Bock highlights the need for innovative manufacturing solutions and supply chain improvements in cell therapy.

The material composition of consumables – whether plastic or glass – impacts their carbon footprints. But which is more efficient?

RNA sequence design is emerging as a path to transform the economics and methodologies of RNA as a drug modality.